Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Lanreotide 30mg powder and solvent for suspension for injection vials |
| BNF code | 0803043P0AAAAAA |
| Virtual Therapeutic Moiety | Lanreotide |
| Date identifier became valid | 29 Oct 2018 |
| Previous product identifier | 327380000 |
| Abbreviated name | Lanreotide 30mg inj vials |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 4 Jun 2004 |
| Previous name | Lanreotide 30mg injection vials and diluent |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products not Available |
| Non-availability status date | 9 Aug 2022 |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | vial |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Lanreotide acetate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 395765000 |
| Strength value numerator | 30.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | suspensioninjection.intramuscular |
| Dose Form | |
| Formulation | Powder and solvent for suspension for injection |
| Drug Route | |
| Route | Intramuscular |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Virtual Medicinal Product Packs | |
| Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.